ESAB appoints Mitchell Rales Executive Chair and grants performance option awards
On June 10, 2026, ESAB appointed Mitchell P. Rales as Executive Chair of the Board and approved performance-based stock option awards for him, CEO Shyam P. Kambeyanda and other senior managers. The awards vest only if the stock meets price hurdles of $140, $170 and $200 over a four-year performance period, which gives shareholders a direct link between management pay and share price. The filing also names Rhonda Jordan as Lead Independent Director.
Key points
- Mitchell P. Rales appointed Executive Chair effective June 10, 2026; he was previously Chairman, appointed in April 2022
- Rales award covers 1,200,000 shares; Kambeyanda award covers 580,552 shares
- Exercise price of $82.92 per share, equal to the NYSE closing price on the June 10, 2026 grant date, with a seven-year term ending June 9, 2033
- Each award vests in three tranches tied to $140, $170 and $200 stock price hurdles measured over a 30-day average during the performance period
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:05 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 12, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.